
About this episode
TWiV reviews results of a phase 3 trial of a self-amplifying mRNA COVID-19 vaccine, and the finding that baseline innate and T cell populations are correlates of protection against symptomatic influenza virus infection independent of serology.
Hosts: Dickson Despommier, Alan Dove and Brianne Barker
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- MicrobeTV Discord Server
- MicrobeTV store at Cafepress
- Michelson Prizes: Next Generation Grants
- Immunogenicity and safety of self-amplifying mRNA COVID-19 vaccine (Lancet Inf Dis)
- First self-amplifying mRNA vaccine approved in Japan (Science)
- Rise of the RNA machines (Trends Biochem)
- Innate and T cell populations correlates of protection against influenza (Nat Immunol)
- Timestamps by Jolene. Thanks!
Weekly Picks
Dickson - Nitrogen-fixing organelle in a marine alga
Brianne – Mapping a lost branch of the Nile
Alan – Interactive version of the updated USDA gardening zone map on NPR.
Intro music is by Ronald Jenkees
Send your virology questions and comments to [email protected]
Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Virology

TWiV 1309: Maybe they're all cancer vaccines
This Week in Virology

TWiV 1308: Clinical update with Dr. Daniel Griffin
This Week in Virology

TWiV 1307: My heart breaks for flu
This Week in Virology

TWiV 1306: Clinical update with Dr. Daniel Griffin
This Week in Virology
